Array Biopharma (ARRY) Closes 23M Share Offering at $2.60/Share

Array Biopharma (Nasdaq: ARRY) closed its previously announced underwritten public offering of 23,000,000 shares of its common stock at a public offering price of $2.60 per share, which includes the exercise in full by the underwriters of the over-allotment option to purchase 3,000,000 shares of common stock. Array received net proceeds from the sale of the shares, after underwriting discounts and commissions and estimated offering expenses, of approximately $56.1 million.

---

Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!

You May Also Be Interested In

• Regency Energy Partners (RGP) Files $200M Common Unit Shelf
• Covidien (COV) Prices $1.250 Billion Senior Notes Offering
• New York Mortgage Trust (NYMT) Prices 2.75M Offering at $6.65/Share

Create E-mail Alert Related Categories

Equity Offerings

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?

Follow StreetInsider.com On Twitter